Reynders, C., Bruyère, D., RONCARATI, P., Geuzaine, R., KOOPMANSCH, B., Gofflot, S., Monnien, F., Craciun, L., Piazzon, N., Hendrick, E., Poulain, F., Lerho, T., Miceli, S., Pilard, C., Ancion, M., Luyckx, M., Renard, M., Lambert, F., Gheit, T., ... Herfs, M. (December 2025). Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma. Modern Pathology, 38 (12), 100853. doi:10.1016/j.modpat.2025.100853 |
Joannes, L., Dupont, L., Stock, L., Arpigny, E., Hubert, P., Ancion, M., Luyckx, M., Abinet, J., Peng, W., Calaldo, D., Noël, A., Marichal, T., Herfs, M., Deroanne, C., & Colige, A. (23 June 2025). The ADAMTS2 metalloproteinase inhibits tumor growth by regulating the innate immune system. Cancer Cell International, 25 (1), 229. doi:10.1186/s12935-025-03880-1 |
Pilard, C., RONCARATI, P., Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Poulain, F., Bruyère, D., LEBEAU, A., Hendrick, E., Crake, R., Peiffer, R., Nokin, M.-J., Peulen, O., Delvenne, P., Hubert, P.* , & Herfs, M.*. (13 March 2025). RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells. Journal for ImmunoTherapy of Cancer, 13 (3), 010753. doi:10.1136/jitc-2024-010753 * These authors have contributed equally to this work. |
Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., Herfs, M., & Hubert, P. (12 June 2023). Approach using "second generation" immune checkpoint inhibitors for the treatment of triple-negative breast cancer [Poster presentation]. EACR 2023, Turin, Italy. |
Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Luyckx, M., Renard, M., Delvenne, P., Hubert, P., & Herfs, M. (02 February 2023). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis [Poster presentation]. Séminaire des chercheurs Télévie 2023. |
Bruyere, D., RONCARATI, P., Lebeau, A., Lerho, T., Poulain, F., Hendrick, E., Pilard, C., Reynders, C., Ancion, M., Luyckx, M., Renard, M., Jacob, Y., Twizere, J.-C., Peiffer, R., Peulen, O., Delvenne, P., Hubert, P., McBride, A., Gillet, N., ... Herfs, M. (2023). Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair. Theranostics, 13 (3), 1130 - 1149. doi:10.7150/thno.78091 |